Cited by 65Mast cells and histamineFood Allergy and Anaphylaxis ResearchDrug-Induced Adverse Reactions

Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone

Open access
Šelb, Julij, Rijavec, Matija, Eržen, Renato, Zidarn, Mihaela, Kopač, Peter, Škerget, Matevž, Bajrović, Nissera, Luzar, Ajda Demšar +7 more·2021·Journal of Allergy and Clinical Immunology

Abstract

Background Clonal mast cell disorders and elevated basal serum tryptase (BST) levels with unknown cause(s) are associated with severe Hymenoptera venom-triggered anaphylaxis (HVA). However, some individuals with clonal disease have a normal BST level (<11.4 ng/mL).Objective Our aim was to evaluate whether screening for KIT p.D816V in the blood is a useful clinical tool to risk-stratify patients with venom allergy.Methods We prospectively recruited 374 patients with Hymenoptera allergy and no overt signs of mastocytosis who were referred to our center during the years 2018 and 2019. KIT p.D816V was determined in their peripheral blood by quantitative PCR, and tryptase genotyping was performed by droplet digital PCR.Results In all, 351 patients (93.9%) had normal levels of BST, and KIT p.D816V was detected in 8% of patients (28 of 351), predominantly in patients with the most severe Mueller grade IV anaphylaxis (18.2% [24 of 132] vs 1.8% in patients with lower grades [4 of 88 with grade III and 0 of 131 with other grades]; P < .001). In grade IV patients with a normal BST level, KIT p.D816V was associated with more severe symptoms, including a significantly higher frequency of loss of consciousness (58.3% [14 of 24] vs 34.3% [37 of 108]; P = .03) and absence of skin symptoms (41.7% [10 of 24] vs 15.7% [17 of 108]; P = .004). Among patients with a normal BST level, KIT p.D816V (OR = 10.25 [95% CI = 3.75-36.14]; P < .0001) was the major risk factor associated with severe HVA. Hereditary α-tryptasemia (HαT) due to increased germline copies of TPSAB1 encoding α-tryptase was the most common cause (65.2% [15 of 23]) of elevated BST level in patients with HVA, and together with KIT p.D816V, it accounted for 90% of BST level elevations (20 of 23) in patients with HVA.Conclusion These results indicate that routine KIT p.D816V screening identifies clonal disease in high-risk patients with HVA who are regularly missed when BST level is used alone.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2021.02.043

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients with systemic mastocytosis and anaphylaxis seem to have a lower baseline serum tryptase in contrast to patients with systemic mastocytosis without anaphylaxis.

    “One should be cautious that patients with SM and anaphylaxis seem to have a lower bST in contrast to patients with SM without anaphylaxis [61,62,63,64,65].”

    From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [64]

    In Results and Discussion (page not provided), the paper reports that one patient with normal baseline serum tryptase and four with elevated levels had severe venom anaphylaxis and met criteria for indolent systemic mastocytosis. This supports the caution that anaphylaxis can occur in systemic mastocytosis despite normal tryptase, but the paper does not compare tryptase levels with patients who have systemic mastocytosis without anaphylaxis. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • HαT is enriched in patients with SM, Hymenoptera-allergic patients with severe anaphylaxis, and patients with idiopathic anaphylaxis.

    “HαT is enriched in patients with SM,42,43 in Hymenoptera-allergic patients with severe anaphylaxis,44,45 and in patients with idiopathic anaphylaxis.42,43,45,46”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 23 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Šelb, J., Rijavec, M., Eržen, R., Zidarn, M., Kopač, P., Škerget, M., Bajrović, N., Luzar, A. D., Park, Y. H., Liu, Y., Šerbec, V. Č., Zver, S., Košnik, M., Lyons, J. J., & Korošec, P.
Affiliations
  • University of Ljubljana (SI)
  • University Clinic of Pulmonary and Allergic Diseases Golnik (SI)
  • National Institutes of Health (US)
  • Blood Transfusion Centre of Slovenia (SI)
Corresponding author
Korošec, Peter
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2021-08
Volume
148
Issue
2
Pages
621-626.e7
ISSN
0091-6749 (ISSN-L)
OpenAlex
W3136573001
Cited by
65
References
23
Citations by year
2026: 10 · 2025: 15 · 2024: 18 · 2023: 9 · 2022: 8 · 2021: 5
FWCI
3.73
Type
journal article
Language
en
Open access
Locations
  • Journal of Allergy and Clinical Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases
  • Javna Agencija za Raziskovalno Dejavnost RS (P3-0360)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
  • Health Sciences › Medicine › Pharmacology › Drug-Induced Adverse Reactions
Keywords
hymenoptera venom allergy, serum tryptase, hereditary alpha-tryptasemia, TPSAB1, risk stratification, anaphylaxis severity, loss of consciousness, mastocytosis, KIT mutations
MeSH terms
Adult, Aged, Aged, 80 and over, Anaphylaxis, Arthropod Venoms, Female, Genetic Testing, Humans, Male, Mast Cells, Middle Aged, Proto-Oncogene Proteins c-kit, Amino Acid Substitution, Mutation, Missense, Mastocytosis, Systemic, Tryptases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review